scispace - formally typeset
M

Michihiro Araki

Researcher at Kyoto University

Publications -  42
Citations -  11631

Michihiro Araki is an academic researcher from Kyoto University. The author has contributed to research in topics: Biology & Computer science. The author has an hindex of 17, co-authored 38 publications receiving 9862 citations. Previous affiliations of Michihiro Araki include Artificial Intelligence Center & Mitsubishi Chemical Corporation.

Papers
More filters
Journal ArticleDOI

KEGG for linking genomes to life and the environment

TL;DR: KEGG PATHWAY is now supplemented with a new global map of metabolic pathways, which is essentially a combined map of about 120 existing pathway maps, and the KEGG resource is being expanded to suit the needs for practical applications.
Journal ArticleDOI

From genomics to chemical genomics: new developments in KEGG

TL;DR: The scope of KEGG LIGAND has been significantly expanded to cover both endogenous and exogenous molecules, and RPAIR contains curated chemical structure transformation patterns extracted from known enzymatic reactions, which would enable analysis of genome-environment interactions.
Journal ArticleDOI

Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems

TL;DR: The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes, and it was demonstrated that off-target effects were comparable to those of conventional CRISpr/Cas systems, with a reduced risk of indel formation.
Journal ArticleDOI

Prediction of drug–target interaction networks from the integration of chemical and genomic spaces

TL;DR: This article characterize four classes of drug–target interaction networks in humans involving enzymes, ion channels, G-protein-coupled receptors (GPCRs) and nuclear receptors, and reveal significant correlations between drug structure similarity, target sequence similarity and the drug– target interaction network topology.
Journal ArticleDOI

Programmable cells: Interfacing natural and engineered gene networks

TL;DR: This work employs a modular design strategy to create Escherichia coli strains where a genetic toggle switch is interfaced with: the SOS signaling pathway responding to DNA damage, and a transgenic quorum sensing signaling pathway from Vibrio fischeri.